vs

Side-by-side financial comparison of Tilray Brands, Inc. (TLRY) and Xperi Inc. (XPER). Click either name above to swap in a different company.

Tilray Brands, Inc. is the larger business by last-quarter revenue ($217.5M vs $116.5M, roughly 1.9× Xperi Inc.). Xperi Inc. runs the higher net margin — -14.7% vs -20.7%, a 6.0% gap on every dollar of revenue. On growth, Tilray Brands, Inc. posted the faster year-over-year revenue change (3.1% vs -4.8%). Over the past eight quarters, Tilray Brands, Inc.'s revenue compounded faster (7.5% CAGR vs -1.0%).

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

Xperi Inc. is an American multinational technology company headquartered in San Jose, California, that develops software for consumer electronics and connected cars, as well as media platforms for video service over broadband. The company is organized into four business units: Pay TV, Consumer Electronics, Connected Car, and Media Platform. Xperi's brands include DTS, HD Radio, and TiVo.

TLRY vs XPER — Head-to-Head

Bigger by revenue
TLRY
TLRY
1.9× larger
TLRY
$217.5M
$116.5M
XPER
Growing faster (revenue YoY)
TLRY
TLRY
+7.9% gap
TLRY
3.1%
-4.8%
XPER
Higher net margin
XPER
XPER
6.0% more per $
XPER
-14.7%
-20.7%
TLRY
Faster 2-yr revenue CAGR
TLRY
TLRY
Annualised
TLRY
7.5%
-1.0%
XPER

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
TLRY
TLRY
XPER
XPER
Revenue
$217.5M
$116.5M
Net Profit
$-44.9M
$-17.1M
Gross Margin
26.4%
Operating Margin
-10.2%
-12.7%
Net Margin
-20.7%
-14.7%
Revenue YoY
3.1%
-4.8%
Net Profit YoY
47.4%
-137.0%
EPS (diluted)
$-0.41
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TLRY
TLRY
XPER
XPER
Q4 25
$217.5M
$116.5M
Q3 25
$209.5M
$111.6M
Q2 25
$224.5M
$105.9M
Q1 25
$185.8M
$114.0M
Q4 24
$210.9M
$122.4M
Q3 24
$200.0M
$132.9M
Q2 24
$229.9M
$119.6M
Q1 24
$188.3M
$118.8M
Net Profit
TLRY
TLRY
XPER
XPER
Q4 25
$-44.9M
$-17.1M
Q3 25
$-322.0K
$-6.1M
Q2 25
$-1.3B
$-14.8M
Q1 25
$-789.4M
$-18.4M
Q4 24
$-85.3M
$46.2M
Q3 24
$-39.2M
$-16.8M
Q2 24
$-31.7M
$-30.3M
Q1 24
$-92.7M
$-13.1M
Gross Margin
TLRY
TLRY
XPER
XPER
Q4 25
26.4%
Q3 25
27.4%
Q2 25
30.1%
Q1 25
28.0%
Q4 24
29.0%
Q3 24
29.8%
Q2 24
35.8%
Q1 24
26.2%
Operating Margin
TLRY
TLRY
XPER
XPER
Q4 25
-10.2%
-12.7%
Q3 25
1.0%
-1.2%
Q2 25
-643.1%
-10.5%
Q1 25
-409.0%
-14.4%
Q4 24
-20.0%
-11.7%
Q3 24
-18.3%
-14.0%
Q2 24
-7.2%
-18.3%
Q1 24
-43.6%
-27.2%
Net Margin
TLRY
TLRY
XPER
XPER
Q4 25
-20.7%
-14.7%
Q3 25
-0.2%
-5.5%
Q2 25
-566.9%
-14.0%
Q1 25
-424.9%
-16.1%
Q4 24
-40.5%
37.8%
Q3 24
-19.6%
-12.6%
Q2 24
-13.8%
-25.3%
Q1 24
-49.2%
-11.0%
EPS (diluted)
TLRY
TLRY
XPER
XPER
Q4 25
$-0.41
$-0.37
Q3 25
$0.00
$-0.13
Q2 25
$7.26
$-0.32
Q1 25
$-8.69
$-0.41
Q4 24
$-0.99
$1.02
Q3 24
$-0.04
$-0.37
Q2 24
$-0.04
$-0.67
Q1 24
$-0.12
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TLRY
TLRY
XPER
XPER
Cash + ST InvestmentsLiquidity on hand
$291.6M
$96.8M
Total DebtLower is stronger
$27.7M
Stockholders' EquityBook value
$1.6B
$414.1M
Total Assets
$2.1B
$615.8M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TLRY
TLRY
XPER
XPER
Q4 25
$291.6M
$96.8M
Q3 25
$264.8M
$96.8M
Q2 25
$256.4M
$95.1M
Q1 25
$88.0M
Q4 24
$252.2M
$130.6M
Q3 24
$280.1M
$72.7M
Q2 24
$260.5M
$92.5M
Q1 24
$225.9M
$95.2M
Total Debt
TLRY
TLRY
XPER
XPER
Q4 25
$27.7M
Q3 25
$27.7M
Q2 25
$27.7M
Q1 25
$27.7M
Q4 24
$27.7M
Q3 24
$27.7M
Q2 24
$27.7M
Q1 24
$27.7M
Stockholders' Equity
TLRY
TLRY
XPER
XPER
Q4 25
$1.6B
$414.1M
Q3 25
$1.5B
$421.0M
Q2 25
$1.5B
$419.8M
Q1 25
$2.7B
$418.9M
Q4 24
$3.5B
$429.1M
Q3 24
$3.5B
$377.4M
Q2 24
$3.4B
$388.7M
Q1 24
$3.4B
$399.1M
Total Assets
TLRY
TLRY
XPER
XPER
Q4 25
$2.1B
$615.8M
Q3 25
$2.1B
$628.8M
Q2 25
$2.1B
$629.2M
Q1 25
$633.5M
Q4 24
$4.2B
$667.8M
Q3 24
$4.3B
$616.2M
Q2 24
$4.2B
$619.2M
Q1 24
$4.2B
$630.4M
Debt / Equity
TLRY
TLRY
XPER
XPER
Q4 25
0.07×
Q3 25
0.07×
Q2 25
0.07×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.07×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TLRY
TLRY
XPER
XPER
Operating Cash FlowLast quarter
$-8.5M
$4.1M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
1.0%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TLRY
TLRY
XPER
XPER
Q4 25
$-8.5M
$4.1M
Q3 25
$-1.3M
$7.5M
Q2 25
$-12.8M
$10.1M
Q1 25
$-5.8M
$-22.3M
Q4 24
$-40.7M
$1.2M
Q3 24
$-35.3M
$-4.6M
Q2 24
$30.7M
$-2.1M
Q1 24
$-15.4M
$-49.8M
Free Cash Flow
TLRY
TLRY
XPER
XPER
Q4 25
$1.2M
Q3 25
$6.7M
Q2 25
$-19.1M
$9.5M
Q1 25
$-20.2M
$-23.3M
Q4 24
$-46.2M
$-510.0K
Q3 24
$-42.0M
$-5.6M
Q2 24
$21.0M
$-2.6M
Q1 24
$-24.9M
$-51.6M
FCF Margin
TLRY
TLRY
XPER
XPER
Q4 25
1.0%
Q3 25
6.0%
Q2 25
-8.5%
9.0%
Q1 25
-10.9%
-20.5%
Q4 24
-21.9%
-0.4%
Q3 24
-21.0%
-4.2%
Q2 24
9.1%
-2.2%
Q1 24
-13.2%
-43.4%
Capex Intensity
TLRY
TLRY
XPER
XPER
Q4 25
2.5%
Q3 25
0.7%
Q2 25
2.8%
0.5%
Q1 25
7.8%
0.9%
Q4 24
2.6%
1.4%
Q3 24
3.4%
0.8%
Q2 24
4.2%
0.4%
Q1 24
5.1%
1.6%
Cash Conversion
TLRY
TLRY
XPER
XPER
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

XPER
XPER

Pay TV$56.2M48%
Connected Car$31.3M27%
Consumer Electronics$17.2M15%
Media Platform$11.8M10%

Related Comparisons